nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A5—Dactinomycin—muscle cancer	0.443	0.466	CbGbCtD
Diphenhydramine—PTGS1—Etoposide—muscle cancer	0.162	0.171	CbGbCtD
Diphenhydramine—CYP1A2—Dacarbazine—muscle cancer	0.148	0.156	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—muscle cancer	0.0844	0.0887	CbGbCtD
Diphenhydramine—CYP1A2—Etoposide—muscle cancer	0.0725	0.0763	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—muscle cancer	0.0408	0.0429	CbGbCtD
Diphenhydramine—Neuritis—Vincristine—muscle cancer	0.00185	0.0383	CcSEcCtD
Diphenhydramine—Chest discomfort—Etoposide—muscle cancer	0.00126	0.0262	CcSEcCtD
Diphenhydramine—Urinary retention—Vincristine—muscle cancer	0.000952	0.0197	CcSEcCtD
Diphenhydramine—Dysuria—Vincristine—muscle cancer	0.000809	0.0168	CcSEcCtD
Diphenhydramine—Agranulocytosis—Dactinomycin—muscle cancer	0.000805	0.0167	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Vincristine—muscle cancer	0.000789	0.0164	CcSEcCtD
Diphenhydramine—Neuritis—Doxorubicin—muscle cancer	0.000776	0.0161	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Vincristine—muscle cancer	0.000756	0.0157	CcSEcCtD
Diphenhydramine—Chills—Dactinomycin—muscle cancer	0.000695	0.0144	CcSEcCtD
Diphenhydramine—Sweating increased—Etoposide—muscle cancer	0.000682	0.0141	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Etoposide—muscle cancer	0.000612	0.0127	CcSEcCtD
Diphenhydramine—Agranulocytosis—Etoposide—muscle cancer	0.000583	0.0121	CcSEcCtD
Diphenhydramine—Agitation—Vincristine—muscle cancer	0.000554	0.0115	CcSEcCtD
Diphenhydramine—Photosensitivity—Methotrexate—muscle cancer	0.000553	0.0115	CcSEcCtD
Diphenhydramine—Vertigo—Vincristine—muscle cancer	0.000541	0.0112	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000539	0.0112	CcSEcCtD
Diphenhydramine—Anorexia—Dactinomycin—muscle cancer	0.000525	0.0109	CcSEcCtD
Diphenhydramine—Convulsion—Vincristine—muscle cancer	0.000522	0.0108	CcSEcCtD
Diphenhydramine—Chills—Etoposide—muscle cancer	0.000503	0.0104	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Vincristine—muscle cancer	0.000482	0.00998	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—muscle cancer	0.000479	0.00992	CcSEcCtD
Diphenhydramine—Decreased appetite—Dactinomycin—muscle cancer	0.000479	0.00992	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Vincristine—muscle cancer	0.000475	0.00985	CcSEcCtD
Diphenhydramine—Fatigue—Dactinomycin—muscle cancer	0.000475	0.00984	CcSEcCtD
Diphenhydramine—Anorexia—Vincristine—muscle cancer	0.000469	0.00972	CcSEcCtD
Diphenhydramine—Irritability—Methotrexate—muscle cancer	0.000463	0.0096	CcSEcCtD
Diphenhydramine—Hypotension—Vincristine—muscle cancer	0.00046	0.00952	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dactinomycin—muscle cancer	0.000454	0.0094	CcSEcCtD
Diphenhydramine—Insomnia—Vincristine—muscle cancer	0.000445	0.00922	CcSEcCtD
Diphenhydramine—Paraesthesia—Vincristine—muscle cancer	0.000442	0.00915	CcSEcCtD
Diphenhydramine—Vertigo—Etoposide—muscle cancer	0.000439	0.00909	CcSEcCtD
Diphenhydramine—Decreased appetite—Vincristine—muscle cancer	0.000428	0.00886	CcSEcCtD
Diphenhydramine—Fatigue—Vincristine—muscle cancer	0.000424	0.00879	CcSEcCtD
Diphenhydramine—Convulsion—Etoposide—muscle cancer	0.000423	0.00877	CcSEcCtD
Diphenhydramine—Constipation—Vincristine—muscle cancer	0.000421	0.00872	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—muscle cancer	0.00042	0.00871	CcSEcCtD
Diphenhydramine—Confusional state—Etoposide—muscle cancer	0.000402	0.00833	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS2—muscle cancer	0.0004	0.402	CrCbGaD
Diphenhydramine—Asthenia—Dactinomycin—muscle cancer	0.000395	0.00819	CcSEcCtD
Diphenhydramine—Dysuria—Methotrexate—muscle cancer	0.000392	0.00813	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Etoposide—muscle cancer	0.00039	0.00808	CcSEcCtD
Diphenhydramine—Tachycardia—Etoposide—muscle cancer	0.000389	0.00806	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Etoposide—muscle cancer	0.000385	0.00798	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000383	0.00794	CcSEcCtD
Diphenhydramine—Anorexia—Etoposide—muscle cancer	0.00038	0.00787	CcSEcCtD
Diphenhydramine—Diarrhoea—Dactinomycin—muscle cancer	0.000377	0.00781	CcSEcCtD
Diphenhydramine—Drowsiness—Methotrexate—muscle cancer	0.000374	0.00775	CcSEcCtD
Diphenhydramine—Hypotension—Etoposide—muscle cancer	0.000372	0.00772	CcSEcCtD
Diphenhydramine—Paraesthesia—Etoposide—muscle cancer	0.000358	0.00741	CcSEcCtD
Diphenhydramine—Somnolence—Etoposide—muscle cancer	0.000354	0.00734	CcSEcCtD
Diphenhydramine—Asthenia—Vincristine—muscle cancer	0.000353	0.00731	CcSEcCtD
Diphenhydramine—Vomiting—Dactinomycin—muscle cancer	0.00035	0.00725	CcSEcCtD
Diphenhydramine—Agranulocytosis—Methotrexate—muscle cancer	0.000349	0.00724	CcSEcCtD
Diphenhydramine—Rash—Dactinomycin—muscle cancer	0.000347	0.00719	CcSEcCtD
Diphenhydramine—Decreased appetite—Etoposide—muscle cancer	0.000346	0.00718	CcSEcCtD
Diphenhydramine—Fatigue—Etoposide—muscle cancer	0.000343	0.00712	CcSEcCtD
Diphenhydramine—Constipation—Etoposide—muscle cancer	0.000341	0.00706	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—muscle cancer	0.00034	0.00704	CcSEcCtD
Diphenhydramine—Diarrhoea—Vincristine—muscle cancer	0.000337	0.00697	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—muscle cancer	0.000336	0.00696	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000332	0.00687	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS2—muscle cancer	0.000331	0.332	CrCbGaD
Diphenhydramine—Feeling abnormal—Etoposide—muscle cancer	0.000328	0.0068	CcSEcCtD
Diphenhydramine—Nausea—Dactinomycin—muscle cancer	0.000327	0.00678	CcSEcCtD
Diphenhydramine—Dizziness—Vincristine—muscle cancer	0.000325	0.00674	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—muscle cancer	0.000324	0.00671	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000318	0.00658	CcSEcCtD
Diphenhydramine—Urticaria—Etoposide—muscle cancer	0.000317	0.00656	CcSEcCtD
Diphenhydramine—Tinnitus—Methotrexate—muscle cancer	0.000313	0.00649	CcSEcCtD
Diphenhydramine—Vomiting—Vincristine—muscle cancer	0.000313	0.00648	CcSEcCtD
Diphenhydramine—Rash—Vincristine—muscle cancer	0.00031	0.00643	CcSEcCtD
Diphenhydramine—Dermatitis—Vincristine—muscle cancer	0.00031	0.00642	CcSEcCtD
Diphenhydramine—Headache—Vincristine—muscle cancer	0.000308	0.00639	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—muscle cancer	0.000302	0.00627	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—muscle cancer	0.000301	0.00625	CcSEcCtD
Diphenhydramine—Nausea—Vincristine—muscle cancer	0.000292	0.00605	CcSEcCtD
Diphenhydramine—Asthenia—Etoposide—muscle cancer	0.000286	0.00592	CcSEcCtD
Diphenhydramine—Vision blurred—Methotrexate—muscle cancer	0.000276	0.00571	CcSEcCtD
Diphenhydramine—Diarrhoea—Etoposide—muscle cancer	0.000273	0.00565	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—muscle cancer	0.000271	0.00562	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS2—muscle cancer	0.000265	0.266	CrCbGaD
Diphenhydramine—Dizziness—Etoposide—muscle cancer	0.000263	0.00546	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—muscle cancer	0.000263	0.00544	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—muscle cancer	0.000261	0.00541	CcSEcCtD
Diphenhydramine—Convulsion—Methotrexate—muscle cancer	0.000253	0.00525	CcSEcCtD
Diphenhydramine—Vomiting—Etoposide—muscle cancer	0.000253	0.00525	CcSEcCtD
Diphenhydramine—Rash—Etoposide—muscle cancer	0.000251	0.00521	CcSEcCtD
Diphenhydramine—Dermatitis—Etoposide—muscle cancer	0.000251	0.0052	CcSEcCtD
Diphenhydramine—Headache—Etoposide—muscle cancer	0.00025	0.00517	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—muscle cancer	0.000248	0.00515	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—muscle cancer	0.000246	0.0051	CcSEcCtD
Diphenhydramine—Confusional state—Methotrexate—muscle cancer	0.000241	0.00499	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—muscle cancer	0.000239	0.00495	CcSEcCtD
Diphenhydramine—Nausea—Etoposide—muscle cancer	0.000237	0.0049	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Methotrexate—muscle cancer	0.000234	0.00484	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—muscle cancer	0.000233	0.00482	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—muscle cancer	0.000231	0.00478	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—muscle cancer	0.000227	0.00471	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—muscle cancer	0.000227	0.00471	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—muscle cancer	0.000224	0.00464	CcSEcCtD
Diphenhydramine—Hypotension—Methotrexate—muscle cancer	0.000223	0.00462	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—muscle cancer	0.000219	0.00455	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—muscle cancer	0.000216	0.00447	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—muscle cancer	0.000214	0.00444	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—muscle cancer	0.000212	0.0044	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—muscle cancer	0.000211	0.00437	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—muscle cancer	0.00021	0.00435	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—muscle cancer	0.000208	0.00432	CcSEcCtD
Diphenhydramine—Decreased appetite—Methotrexate—muscle cancer	0.000207	0.0043	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—muscle cancer	0.000206	0.00426	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000202	0.00419	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—muscle cancer	0.000202	0.00418	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—muscle cancer	0.0002	0.00414	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—muscle cancer	0.000197	0.00408	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methotrexate—muscle cancer	0.000197	0.00408	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—muscle cancer	0.000193	0.004	CcSEcCtD
Diphenhydramine—Urticaria—Methotrexate—muscle cancer	0.00019	0.00393	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—muscle cancer	0.000187	0.00387	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—muscle cancer	0.000186	0.00385	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—muscle cancer	0.000184	0.00381	CcSEcCtD
Diphenhydramine—Dyspepsia—Doxorubicin—muscle cancer	0.000182	0.00377	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—muscle cancer	0.00018	0.00372	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—muscle cancer	0.000178	0.00369	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—muscle cancer	0.000177	0.00366	CcSEcCtD
Diphenhydramine—Asthenia—Methotrexate—muscle cancer	0.000171	0.00355	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—muscle cancer	0.00017	0.00353	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—muscle cancer	0.000164	0.0034	CcSEcCtD
Diphenhydramine—Diarrhoea—Methotrexate—muscle cancer	0.000163	0.00338	CcSEcCtD
Diphenhydramine—Dizziness—Methotrexate—muscle cancer	0.000158	0.00327	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—muscle cancer	0.000152	0.00314	CcSEcCtD
Diphenhydramine—Rash—Methotrexate—muscle cancer	0.00015	0.00312	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—muscle cancer	0.00015	0.00312	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—muscle cancer	0.00015	0.0031	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—muscle cancer	0.000148	0.00307	CcSEcCtD
Diphenhydramine—Nausea—Methotrexate—muscle cancer	0.000142	0.00294	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—muscle cancer	0.000141	0.00293	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—muscle cancer	0.000137	0.00283	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—muscle cancer	0.000131	0.00272	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—muscle cancer	0.00013	0.0027	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—muscle cancer	0.00013	0.0027	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—muscle cancer	0.000129	0.00268	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—muscle cancer	0.000123	0.00254	CcSEcCtD
